Your browser doesn't support javascript.
Infectious Disease Alert Updates
Infectious Disease Alert ; 42(4):45261.0, 2023.
Article in English | CINAHL | ID: covidwho-2238073
ABSTRACT
The article discusses the retrospective cohort study performed at the Mayo Clinic in Minnesota from February to June 2022, the first peer-reviewed publication demonstrating the efficacy of the monoclonal antibody bebtelovimab in the prevention of severe COVID-19 infection compared with nirmatrelvir/ritonavir. It mentions that the Food and Drug Administration has issued emergency use authorizations for six new monoclonal antibodies in the fight against SARS-CoV-2.
Keywords
Search on Google
Collection: Databases of international organizations Database: CINAHL Language: English Journal: Infectious Disease Alert Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: Databases of international organizations Database: CINAHL Language: English Journal: Infectious Disease Alert Year: 2023 Document Type: Article